Top Tweets for #PER_CFS

almost 5 years ago

Despite significant therapeutic advancements in the past 2 decades that have resulted in improved survival, myeloma remains an incurable disease. @MountSinaiNYC @gotoPER #gotoCFS #CFS2021 #PER_CFS #mmsm https://t.co/Ekw75YBPnu

OncLive's tweet photo. Despite significant therapeutic advancements in the past 2 decades that have resulted in improved survival, myeloma remains an incurable disease. @MountSinaiNYC @gotoPER #gotoCFS #CFS2021 #PER_CFS #mmsm https://t.co/Ekw75YBPnu https://t.co/MzRrwpTXvu

0

2

1

0

0

almost 5 years ago

CAR T-cell therapy and bispecific antibodies for T-cell redirection are 2 recent immune strategies developed in the treatment of multiple melanoma. @MountSinaiNYC @gotoPER #gotoCFS #CFS2021 #PER_CFS #mmsm https://t.co/MkHJzAJeLi

0

2

2

0

0

almost 5 years ago

Thank you everyone for joining us for The 39th Annual CFS®: Innovative Cancer Therapy for Tomorrow® Make sure you register early for next year to reserve your spot! https://t.co/tF3IB8Xjb7 #gotoPER #gotoCFS #CFS2021 #PER_CFS #CFS2022

0

3

0

0

0

almost 5 years ago

It’s great to be back live and in person at The 39th Annual CFS®: Innovative Cancer Therapy for Tomorrow®. Happening now until November 5, 2021! Join us tomorrow: https://t.co/UskRLwrVls #GoToPER #GotoCFS #CFS2021 #PER_CFS

gotoPER's tweet photo. It’s great to be back live and in person at The 39th Annual CFS®: Innovative Cancer Therapy for Tomorrow®. Happening now until November 5, 2021! Join us tomorrow: https://t.co/UskRLwrVls
#GoToPER #GotoCFS #CFS2021 #PER_CFS https://t.co/404l8VQoPO

0

1

0

0

0

donnashort @donnashort

almost 7 years ago

First talk on testes cancer at #per_cfs in a long time says chair @WilliamOhMD oh no pressure there! @DrDarrenFeldman gives an update with @philtalamo @gotoPER poor risk patients have nonseminoma and nonseminoma are always poor risk. Seek to subplant BEP. @sloan_kettering

donnashort's tweet photo. First talk on testes cancer at #per_cfs in a long time says chair @WilliamOhMD oh no pressure there! @DrDarrenFeldman gives an update with @philtalamo @gotoPER poor risk patients have nonseminoma and nonseminoma are always poor risk. Seek to subplant BEP. @sloan_kettering https://t.co/lRsVN30CEu

1

4

1

0

0

donnashort @donnashort

almost 7 years ago

New era in checkpoint inhibition in #urothelial cancers says Dr Bajorin with moderator @ArjunBalarMD #likesthemusic @gotoPER #per_cfs @sloan_kettering @nyulangone @chemotherapyfdn

donnashort's tweet photo. New era in checkpoint inhibition in #urothelial cancers says Dr Bajorin with moderator @ArjunBalarMD #likesthemusic @gotoPER #per_cfs @sloan_kettering @nyulangone @chemotherapyfdn https://t.co/bPAKHyHQO5

0

2

0

0

0

donnashort @donnashort

almost 7 years ago

Leading a @MedicalXFire @ArjunBalarMD rallies a lively discussion in hormone sensitive #prostatecancer with @Sethbla Dr Kantoff and @ChapinMD radiation vs Medical oncology. Who wins? Patients! @gotoPER #per_cfs @nyulangone @MDAndersonNews @WeillCornell @chemotherapyfdn

donnashort's tweet photo. Leading a @MedicalXFire @ArjunBalarMD rallies a lively discussion in hormone sensitive #prostatecancer with @Sethbla Dr Kantoff and @ChapinMD radiation vs Medical oncology. Who wins? Patients! @gotoPER #per_cfs @nyulangone @MDAndersonNews @WeillCornell @chemotherapyfdn https://t.co/46ok42xR5T

1

6

1

0

0

donnashort @donnashort

almost 7 years ago

Intermittent therapy in #prostatecancer may be having a Renaissance says @sartor_oliver @gotoPER #per_cfs @chemotherapyfdn with chair @WilliamOhMD @philtalamo @MtSinaiQueens @TulaneUrology

0

2

0

0

0

donnashort @donnashort

almost 7 years ago

Patients with #prostatecancer are living longer but they are still dying of their disease says chair @WilliamOhMD with @philtalamo @gotoPER #per_cfs @MtSinaiQueens @chemotherapyfdn

donnashort's tweet photo. Patients with #prostatecancer are living longer but they are still dying of their disease says chair @WilliamOhMD with @philtalamo @gotoPER #per_cfs @MtSinaiQueens @chemotherapyfdn https://t.co/MtQTq68M0C

0

3

0

0

0

donnashort @donnashort

almost 7 years ago

While looking forward it is sometimes good to look backwards in #rcc says Dr Cho with chair @WilliamOhMD @gotoPER #per_cfs @MtSinaiQueens @chemotherapyfdn @nyulangone

donnashort's tweet photo. While looking forward it is sometimes good to look backwards in #rcc says Dr Cho with chair @WilliamOhMD @gotoPER #per_cfs @MtSinaiQueens @chemotherapyfdn @nyulangone https://t.co/PeO8lzXsnV

0

3

0

0

0

donnashort @donnashort

almost 7 years ago

What should we chose in first line #rcc? Risk classification really helps us determine response to tki treatment says @motzermd with chair @WilliamOhMD @gotoPER #per_cfs @sloan_kettering @MtSinaiQueens @chemotherapyfdn

donnashort's tweet photo. What should we chose in first line #rcc? Risk classification really helps us determine response to tki treatment says @motzermd with chair @WilliamOhMD @gotoPER #per_cfs @sloan_kettering @MtSinaiQueens @chemotherapyfdn https://t.co/4uiST1HNYM

1

4

0

0

0

donnashort @donnashort

almost 7 years ago

International expert in #cnslymphoma Dr Rubenstein says 20% manifests in the eye so can be treated as intraocular #lymphoma @gotoPER #per_cfs with moderator Dr Evens @RutgersCancer @UCSFCancer

donnashort's tweet photo. International expert in #cnslymphoma Dr Rubenstein says 20% manifests in the eye so can be treated as intraocular #lymphoma @gotoPER #per_cfs with moderator Dr Evens @RutgersCancer @UCSFCancer https://t.co/IZYYGFAMtH

0

5

0

0

0

donnashort @donnashort

almost 7 years ago

Who should get a plus avd in #hodgkinslymphoma asks Dr Evens @gotoPER #per_cfs @RutgersCancer putting it in context has improved mpfs and PFS

0

3

0

0

0

donnashort @donnashort

almost 7 years ago

When can we stop tki or IO in #cml? @DrEllenRitchie covers the guidance for monitoring patients off treatment with moderator Dr Evens @gotoPER #per_cfs @WeillCornell @RutgersCancer #nyc @chemotherapyfdn

donnashort's tweet photo. When can we stop tki or IO in #cml? @DrEllenRitchie covers the guidance for monitoring patients off treatment with moderator Dr Evens @gotoPER #per_cfs @WeillCornell @RutgersCancer #nyc @chemotherapyfdn https://t.co/Pr1itax87V

0

3

0

0

0

donnashort @donnashort

almost 7 years ago

Two dozen different agents now targeting bcma in #MultipleMyeloma says Dr Mailankody with moderator Dr Chari @philtalamo @gotoPER #per_cfs @chemotherapyfdn #nyc @sloan_kettering @MtSinaiQueens

donnashort's tweet photo. Two dozen different agents now targeting bcma in #MultipleMyeloma says Dr Mailankody with moderator Dr Chari @philtalamo @gotoPER #per_cfs @chemotherapyfdn #nyc @sloan_kettering @MtSinaiQueens https://t.co/IlWkdgZ4jb

0

2

0

0

0

donnashort @donnashort

almost 7 years ago

What is sequencing in #myeloma since we must consider comorbidities says Dr Chari with @philtalamo @gotoPER #per_cfs no myeloma curve is ever flat @MTSINAINYC #nyc @chemotherapyfdn

0

2

0

0

0

donnashort @donnashort

almost 7 years ago

Very exciting new tools in #ALL including adding antibodies versus chemotherapy to our regimens says @DrHKantarjian with moderator @DrPinkalDesai @philtalamo @gotoPER #per_cfs @chemotherapyfdn @MDAndersonNews @WeillCornell #nyc

donnashort's tweet photo. Very exciting new tools in #ALL including adding antibodies versus chemotherapy to our regimens says @DrHKantarjian with moderator @DrPinkalDesai @philtalamo @gotoPER #per_cfs @chemotherapyfdn @MDAndersonNews @WeillCornell #nyc https://t.co/dpmhAFoaHk

0

2

0

0

0

donnashort @donnashort

almost 7 years ago

When are good risk intermediate risk actually bad in #aml? MRD following induction helps us move onto transplantation says Dr Goldberg with moderator @DrPinkalDesai @philtalamo @Movember @gotoPER #per_cfs @HackensackUMC @WeillCornell

donnashort's tweet photo. When are good risk intermediate risk actually bad in #aml? MRD following induction helps us move onto transplantation says Dr Goldberg with moderator @DrPinkalDesai @philtalamo @Movember @gotoPER #per_cfs @HackensackUMC @WeillCornell https://t.co/RTiHwvivhb

0

2

1

0

0

donnashort @donnashort

almost 7 years ago

Tackling all the recent approvals in #aml in 12 minutes @DrPinkalDesai presents @gotoPER #per_cfs @chemotherapyfdn @WeillCornell #lovethismeeting!

donnashort's tweet photo. Tackling all the recent approvals in #aml in 12 minutes @DrPinkalDesai presents @gotoPER #per_cfs @chemotherapyfdn @WeillCornell #lovethismeeting! https://t.co/qUuVib7VsH

0

8

1

0

0

donnashort @donnashort

almost 7 years ago

Dr Sawas says ACHP therapy is standard of care in peripheral c cell #lymphoma with moderator @docbraunstein @gotoPER #per_cfs @ColumbiaMed @nyulangone #nyc

donnashort's tweet photo. Dr Sawas says ACHP therapy is standard of care in peripheral c cell #lymphoma with moderator @docbraunstein @gotoPER #per_cfs @ColumbiaMed @nyulangone #nyc https://t.co/ly6GbSGaoV

0

2

0

0

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users